Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-177-9 | CAS number: 5698-98-6
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP, guidline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Magnesium acrylate
- EC Number:
- 227-177-9
- EC Name:
- Magnesium acrylate
- Cas Number:
- 5698-98-6
- Molecular formula:
- C3H4O2.1/2Mg
- IUPAC Name:
- magnesium diacrylate
- Test material form:
- other: liquid
- Details on test material:
- aqueous solution of magnesium acrylate, 46.41 %
density: 1.248 g/ml
purity (based on 100% magnesium acrylate): 99.7%
pH-value: 6.4
colour: brown,
storage: at room temperature in darkness
expiry date: 18. November 2012
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Elevage Janvier, F-53940 Le Genest St Isle, France
- Age at study initiation: 8 weeks
- Weight at study initiation: 190 - 203 g
- Fasting period before study: no
- Housing: by groups of three
- Diet: ad libitum
- Water: ad libitum
- Acclimatization: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25
- Humidity (%): 30-70
- Air changes (per hr): 10 - 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 46.41% magnesium acrylate solution in water (test item) was applied as supplied by the sponsor without any use of further vehicle.
- Amount of vehicle (if gavage): 3.526 ml/kg body weight corresponding to 4400 mg/kg body weight of pure test item based on the density of 1.248 g/ml - Doses:
- 2042 mg Magnesium acrylate/kg body weight corresponding to 4400 mg/kg b.w. of the test item as supplied by the sponsor (46.41% solution with a density of 1.248 g/ml)
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily (clinical signs)
- Frequency of weighing: D0, 2, 7 and day 14
- Necropsy of survivors performed: yes
The study was performed in two steps. In the first and the second step of the study, the test item was administered by stomach tube under a volume of 3.526 ml/kg body weight (corresponding to 4400 mg/kg b.w. of the test item as supplied by the sponsor (Density 1.248 g/ml)) using a suitable graduated syringe fitted with an metal canula.
Results and discussion
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 042 mg/kg bw
- Based on:
- act. ingr.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 4 400 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 46.61 % magnesium acrylate aqueous solution
- Mortality:
- no mortality occcured during the study
- Clinical signs:
- other: no clinical signs ofserved
- Gross pathology:
- no abnormal findings
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
- Conclusions:
- The LD 50 of Magnesium acrylate in a 46.41% test item solution is higher than 2000 mg Magnesium acrylate/kg body weight after oral administration by gavage in the rat.
- Executive summary:
A magnesium acrylate solution in water, 46.41 %, was administered to 2 groups of 3 female Sprague-Dawley rats by stomach tube. After repeated administration of 2042 mg/kg b.w. in 3.526 ml/kg b.w. no clinical signs and no mortality were observed.
After administration the body weight gain in both groups was still positive. The dissection of the animals at the end of the study revealed no macroscopic changes.
According to the results of this study the LD50 of Magnesium acrylate is higher than 2000 mg/kg b.w. and higher than 4400 mg/kg b.w. for Magnesium acrylate aqueous solution (46.41% solid content).
According to the criteria for classification, packing and labelling of dangerous substances and preparations in accordance with the EEC Directives 67/548, 2001/59 and 1999/45, the test item Magnesium acrylate solution must not be classified.
No symbol or risk phrase is required.
In accordance with the Regulation EC No. 1272/2008 on classification , labelling and packing of substances and mixtures, the test item must not be classified. No signal word or hazard statement is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
